Veracyte (VCYT) is up 26.4%, or $9.55 to $45.67.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VCYT:
- Veracyte price target raised to $43 from $40 at Canaccord
- Veracyte price target raised to $48 from $42 at UBS
- Veracyte’s Strong Financial Performance and Promising Pipeline Justify Buy Rating
- Veracyte’s Strong Financial Performance and Growth Prospects Justify Buy Rating and Increased Price Target
- Veracyte Reports Strong Q3 2025 Financial Performance